Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">INCB18424: Phase II started</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Last quarter, Incyte began an open-label, U.S. Phase II trial of oral INCB18424 in 41 patients. ......

cancer

Genitourinary

INCB18424: Phase II started

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Discovery & Translation Analysis

Discovery & Translation

Hot Topics

BioCentury Podcasts 

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data Coverage

BCIQ Data

All Events

At the East-West Summit, you will meet key players looking to globalize innovation from across Asia.

East-West Biopharma Summit 2026

Bio€quity Europe

Grand Rounds — U.S.

Grand Rounds — Europe

China Healthcare Summit Inquiry

Podcast: The BioCentury Show

Podcast: BioCentury This Week

Webinars

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Subscription

Sponsorship & Branding Inquiry

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Request a Trial

Contact

Home